INCENTIVE COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Compensation Cost and Income Tax Benefit

Compensation costs and the income tax benefit recognized for our stock-based compensation arrangements are included below:

	2023		2022		2021
	(In thousands)
Equity-based awards compensation cost:
Cost of sales	$	629	$	959	$	3,209
Selling, general and administrative expense	6,958		5,904		7,420
Total cost	7,587		6,863		10,629
Income tax benefit	1,836		1,671		2,587
Net cost	$	5,751	$	5,192	$	8,042
Liability-based awards compensation cost:
Selling, general and administrative expense	$	2,491	$	1,773	$	7,715
Income tax benefit	603		432		1,878
Net cost	$	1,888	$	1,341	$	5,837

Schedule of RSU Activity

The Company’s RSU activity is included below:

	2023			2022			2021
	Number	Weighted Average Milestone Date Fair Value(a)		Number	Weighted Average Milestone Date Fair Value(a)		Number	Weighted Average Milestone Date Fair Value(a)
	(In thousands, except weighted average fair values)
Equity-based RSUs:
Outstanding at beginning of year	993	$	22.00	554	$	20.40	584	$	22.12
Transferred to liability-based awards	—	—		—	—		(8)	23.53
Granted	324	23.67		405	23.88		817	21.58
Vested	(378)	22.25		(266)	23.25		(153)	19.48
Awards reinstated (forfeited)	(28)	24.99		300	23.52		(686)	23.44
Outstanding at end of year	911	$	22.40	993	$	22.00	554	$	20.40

	2023			2022			2021
	Number	Weighted Average Milestone Date Fair Value(a)		Number	Weighted Average Milestone Date Fair Value(a)		Number	Weighted Average Milestone Date Fair Value(a)
	(In thousands, except weighted average fair values)
Liability-based RSUs:
Outstanding at beginning of year	377	$	23.80	574	$	27.55	267	$	19.35
Transferred from equity-based awards	—	—		—	—		8	23.53
Granted	158	24.21		269	22.09		358	21.61
Vested	(196)	25.27		(139)	27.55		(59)	20.10
Forfeited	(97)	22.81		(327)	24.71		—	—
Outstanding at end of year	242	$	27.66	377	$	23.80	574	$	27.55

(a)The milestone date fair value is either the closing price of the Company’s common stock on the grant date for equity-based awards or the closing price of a share of the Company’s common stock on the respective milestone date for cash-based liability-based awards (i.e., grant date, vesting date, forfeiture date or financial reporting date).